SRISAI BIOPHARMACEUTICAL SOLUTIONS LLC

Srisai Biopharmaceutical Solutions LLC specializes in the secure, temperature-controlled storage and logistics of sensitive biological materials for federal research programs. Their core capabilities center on refrigerated warehousing of biospecimens—including fetal bovine serum and human samples—with rigorous chain-of-custody protocols, dry ice logistics, and environmental monitoring systems compliant with NIH and CDC standards. The contractor delivers end-to-end biospecimen management services, integrating secure storage, inventory tracking, and just-in-time distribution for large-scale population health studies such as NHANES. Technical expertise includes validated cold chain operations, bio-banking infrastructure, and compliance with 21 CFR Part 11 and GLP guidelines, ensuring sample integrity for downstream diagnostic and genomic analysis. The company maintains a consistent, long-standing relationship with the Department of Health and Human Services, primarily supporting the National Institutes of Health and Centers for Disease Control and Prevention through sustained biospecimen storage and logistics for national health surveillance initiatives. Their work for HHS is characterized by recurring, multi-year engagements focused on mission-critical biorepository operations. A single contract with the Department of Defense highlights their ability to support biotechnology research infrastructure under defense-related programs. Srisai’s primary industry focus is in refrigerated warehousing and storage (NAICS 493120), where they serve as a specialized provider for biomedical research ecosystems. They also deliver medical laboratory support services (NAICS 621511) and facilities management for biosafety-critical environments, positioning themselves as a niche vendor for federal biorepository operations rather than a broad-service logistics firm. As a small business structured as 2K, Srisai Biopharmaceutical Solutions LLC operates from Frederick, Maryland, leveraging its proximity to federal research hubs. The company holds no formal government certifications but demonstrates deep operational compliance through consistent performance on high-integrity federal contracts involving controlled biological materials.